Canadian General Medical Center Complex Company (TADAWUL:4021)
Saudi Arabia · Delayed Price · Currency is SAR 5.51
-0.26 (-4.51%)
At close: Jul 13, 2026
TADAWUL:4021 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 156.19 | 148.23 | 110.8 | 100.34 | 81.23 | 70.64 | |
Revenue Growth (YoY) | 35.48% | 33.78% | 10.42% | 23.53% | 14.99% | 10.01% |
Cost of Revenue | 113.37 | 104.74 | 82.36 | 68.8 | 56.26 | 45.51 |
Gross Profit | 42.82 | 43.49 | 28.45 | 31.54 | 24.97 | 25.13 |
Selling, General & Admin | 25.1 | 23.82 | 16.64 | 9.51 | 7.28 | 8.45 |
Operating Expenses | 26.12 | 25.69 | 17.02 | 15.98 | 7.88 | 8.95 |
Operating Income | 16.7 | 17.81 | 11.43 | 15.56 | 17.09 | 16.19 |
Interest Expense | -0.57 | -0.55 | -0.51 | -0.33 | -0.56 | -0.35 |
Interest & Investment Income | 0.15 | 0.15 | 1.83 | 2.4 | 0.97 | - |
Other Non Operating Income (Expenses) | -0.01 | 0.08 | 0.08 | 0.27 | 0.25 | 0.31 |
EBT Excluding Unusual Items | 16.27 | 17.49 | 12.83 | 17.91 | 17.75 | 16.14 |
Gain (Loss) on Sale of Investments | -8.2 | -4.95 | 0.07 | - | 0.23 | 0.38 |
Gain (Loss) on Sale of Assets | -0 | -0 | -0.01 | -0.04 | -0 | 0 |
Pretax Income | 8.07 | 12.54 | 12.89 | 17.86 | 17.97 | 16.53 |
Income Tax Expense | 1.98 | 2.05 | 2.63 | 2.15 | 2.32 | 2.47 |
Net Income | 6.09 | 10.5 | 10.27 | 15.71 | 15.65 | 14.06 |
Net Income to Common | 6.09 | 10.5 | 10.27 | 15.71 | 15.65 | 14.06 |
Net Income Growth | -62.00% | 2.22% | -34.63% | 0.36% | 11.31% | -12.94% |
Shares Outstanding (Basic) | 77 | 77 | 77 | 77 | 77 | 77 |
Shares Outstanding (Diluted) | 77 | 77 | 77 | 77 | 77 | 77 |
Shares Change (YoY) | -0.00% | - | - | - | - | 1900.35% |
EPS (Basic) | 0.08 | 0.14 | 0.13 | 0.20 | 0.20 | 0.18 |
EPS (Diluted) | 0.08 | 0.14 | 0.13 | 0.20 | 0.20 | 0.18 |
EPS Growth | -62.00% | 2.22% | -34.63% | 0.36% | 11.31% | -95.65% |
Free Cash Flow | 15.28 | 10.52 | -3.9 | 9.39 | 16.43 | -0.05 |
Free Cash Flow Per Share | 0.20 | 0.14 | -0.05 | 0.12 | 0.21 | -0.00 |
Dividend Per Share | 0.130 | 0.130 | 0.050 | 0.190 | 0.200 | 0.300 |
Dividend Growth | 160.00% | 160.00% | -73.68% | -5.00% | -33.33% | - |
Gross Margin | 27.42% | 29.34% | 25.67% | 31.43% | 30.74% | 35.58% |
Operating Margin | 10.69% | 12.01% | 10.31% | 15.51% | 21.04% | 22.91% |
Profit Margin | 3.90% | 7.08% | 9.27% | 15.66% | 19.27% | 19.91% |
Free Cash Flow Margin | 9.79% | 7.10% | -3.52% | 9.36% | 20.23% | -0.06% |
EBITDA | 21.04 | 21.6 | 13.43 | 16.48 | 19.01 | 18.42 |
EBITDA Margin | 13.47% | 14.57% | 12.12% | 16.42% | 23.41% | 26.08% |
D&A For EBITDA | 4.34 | 3.79 | 2 | 0.92 | 1.92 | 2.23 |
EBIT | 16.7 | 17.81 | 11.43 | 15.56 | 17.09 | 16.19 |
EBIT Margin | 10.69% | 12.01% | 10.31% | 15.51% | 21.04% | 22.91% |
Effective Tax Rate | 24.50% | 16.31% | 20.36% | 12.05% | 12.90% | 14.92% |
Advertising Expenses | - | - | - | 0.02 | - | - |